Lista de obras -

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

artículo científico publicado en 2002

A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer

artículo científico publicado en 2012

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

artículo científico publicado en 2015

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

artículo científico publicado en 2010

Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families

artículo científico publicado en 2008

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.

artículo científico publicado en 2016

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

artículo científico publicado en 2011

Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival

artículo científico publicado en 2005

Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications

artículo científico publicado en 2011

CHEK2 variant I157T may be associated with increased breast cancer risk

artículo científico publicado en 2004

Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors.

artículo científico publicado en 2006

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

artículo científico publicado en 2005

Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer

artículo científico publicado en 2008

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.

artículo científico publicado en 2018

Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment

artículo científico publicado en 2013

Evaluation ofRAD50 in familial breast cancer predisposition

Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.

artículo científico publicado en 2008

Family history influences the tumor characteristics and prognosis of breast cancers developing during postmenopausal hormone therapy

artículo científico publicado en 2017

Field study of a web service for stimulating the positive side of stress: entrepreneurs' experiences and design implications

scientific article published on 28 October 2019

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

artículo científico publicado en 2013

Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes

artículo científico publicado en 2016

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer

artículo científico publicado en 2013

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics

artículo científico publicado en 2010

Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients

article published in 2010

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers

artículo científico publicado en 2015

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

artículo científico publicado en 2004

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

artículo científico publicado en 2011

Mast cells and eosinophils in invasive breast carcinoma

artículo científico publicado en 2007

Metaplastic carcinoma of the breast: Prognosis and response to systemic treatment in metastatic disease

scientific article published on 29 March 2019

MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer

artículo científico publicado en 2011

Molecular subtypes of breast cancers detected in mammography screening and outside of screening

artículo científico publicado en 2008

NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer

artículo científico publicado en 2008

NQO1 expression correlates inversely with NFκB activation in human breast cancer

article published in 2011

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

artículo científico publicado en 2011

Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium

artículo científico publicado en 2016

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

artículo científico publicado en 2014

Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy

artículo científico publicado en 2019

Prognostic role of HuR in hereditary breast cancer

artículo científico publicado en 2007

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

artículo científico publicado en 2014

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families

artículo científico publicado en 2005

Reply-Letter to the editor

artículo científico publicado en 2019

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

artículo científico publicado en 2010

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

artículo científico publicado en 2017

The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype

artículo científico publicado en 2009

The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer

artículo científico publicado en 2012

Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer

article published in 2012

VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors.

artículo científico publicado en 2008

Variants on the promoter region of PTEN affect breast cancer progression and patient survival

artículo científico publicado en 2011

Lista de obras de

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival

Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications

CHEK2 variant I157T may be associated with increased breast cancer risk

Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors.

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.

Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment

Evaluation ofRAD50 in familial breast cancer predisposition

Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.

Family history influences the tumor characteristics and prognosis of breast cancers developing during postmenopausal hormone therapy

Field study of a web service for stimulating the positive side of stress: entrepreneurs' experiences and design implications

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics

Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

Mast cells and eosinophils in invasive breast carcinoma

Metaplastic carcinoma of the breast: Prognosis and response to systemic treatment in metastatic disease

MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer

Molecular subtypes of breast cancers detected in mammography screening and outside of screening

NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer

NQO1 expression correlates inversely with NFκB activation in human breast cancer

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy

Prognostic role of HuR in hereditary breast cancer

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families

Reply-Letter to the editor

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype

The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer

Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer

VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors.

Variants on the promoter region of PTEN affect breast cancer progression and patient survival